
Targeting metabolic pathways could offer a new approach to treating ARDS. The review highlights how carbohydrate, amino acid, and lipid metabolism disruptions worsen inflammation and oxidative stress in ARDS patients. Metabolic dysfunctions exacerbate lung injury and affect patient outcomes. The study suggests that regulating metabolic pathways may provide a promising therapeutic strategy for ARDS management and improved recovery by analyzing key metabolites and potential drugs.
Like
Save
Share